Washington, D.C. – The Food and Drug Administration (FDA) is expected to issue a new series of guidelines for emergency authorization for any COVID-19 vaccine. This creates another layer of security in the vaccine trial process — directly contradicting President Trump’s promise to have a vaccine widely available to the public by next month.
—
Image Credit: CDC Image Library
To learn what the Department of Health and Human Services had to say about these guidelines, become a subscriber and get access to our premium news content!
Lead developer and editor; legal/political reporter for the Current Affairs Times. World traveler. Mac 'n' cheese lover.